# Lunai Bioworks Plans Nasdaq Delisting After $9.02 Million Deficit

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/39329
Published: 2026-10-23T21:12:56.000Z
Updated: 2026-10-23T21:12:56.000Z
Section: Business

> Trading in its common stock is expected to be suspended Oct. 30, with the delisting expected to take effect around Nov. 12.

Lunai Bioworks Inc. (LNAI) plans to delist from Nasdaq after the exchange determined it failed the $2.5 million stockholders’ equity requirement, with trading in its common stock expected to be suspended at the opening of business Friday, Oct. 30.

Lunai had a stockholders’ deficit of $9.02 million as of June 30, 2026. Nasdaq’s minimum equity threshold is $2.5 million.

The company plans to file Form 25 with the Securities and Exchange Commission around Nov. 2. The delisting is expected to take effect around Nov. 12.